Parters L P Domain VII's Net Worth

$95.7 Million

Estimate Recalculated Sep 18, 2024 04:08PM EST

Who is Parters L P Domain VII?

Parters L P Domain VII has an estimated net worth of $95.7 Million. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., ZOGENIX, INC., TANDEM DIABETES CARE INC, Esperion Therapeutics, Inc., Clovis Oncology, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, Neothetics, Inc., Achaogen Inc, Regado Biosciences Inc, and CADENCE PHARMACEUTICALS INC.

SEC CIK

Parters L P Domain VII's CIK is 0001374150

Past Insider Trading and Trends

2009 was Parters L P Domain VII's most active year for acquiring shares with 15 total transactions. Parters L P Domain VII's most active month to acquire stocks was the month of October. 2014 was Parters L P Domain VII's most active year for disposing of shares, totalling 16 transactions. Parters L P Domain VII's most active month to dispose stocks was the month of October. 2011 saw Parters L P Domain VII paying a total of $26,143,926.10 for 7,354,771 shares, this is the most they've acquired in one year. In 2013 Parters L P Domain VII cashed out on 7,578,312 shares for a total of $16,429,220.79, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OBALON THERAPEUTICS INC (RSLS) Snapshot price: $0.1471

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+44.37%
250K
$4.00
$1,000,000.00
813.43K
Aug 6
Form 4
+41.35%
1.65M
$1.82
$3,000,013.38
5.63M
Aug 23
Form 4
∞
3.99M
—
—
3.99M
Oct 12
Form 3
—
0
—
—
0
No matching records found

Neothetics, Inc. (EVFM) Snapshot price: $0.0099

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
∞
3.09M
$11.86
-$2,202,438.00
3.09M
Nov 25
Form 3/A
—
0
—
—
0
Form 4
∞
3.09M
$11.86
-$2,202,438.00
3.09M
Nov 25
Form 3
—
0
—
—
0
No matching records found

Regado Biosciences Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.63%
-350.00K
—
—
2.22M
Mar 20
Form 4
+24.19%
500K
$20.00
$10,000,000.00
2.57M
Oct 21
Form 4
∞
2.07M
$14.00
—
2.07M
Jul 1
Form 3
—
0
—
—
0
No matching records found

Clovis Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.81%
-159.19K
$64.58
-$10,280,619.36
2.58M
Jun 4
Form 4
-8.36%
-250.00K
$24.59
-$6,148,601.43
2.74M
Mar 4 - Mar 6
Form 4
+243.65%
2.99M
$13.00
—
4.22M
Nov 21
Form 3
—
0
—
—
0
No matching records found